Evidence map›Paper›PMID 37020891›Full record

ArticleRSC advances2023

Effect of autohydrolysis and ionosolv treatments on eucalyptus fractionation and recovered lignin properties.

Antonio Ovejero-Pérez, Victoria Rigual, Juan C Domínguez, M Virginia Alonso, Mercedes Oliet, Francisco Rodriguez

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonio Ovejero-PérezDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.ORCID https://orcid.org/0000-0001-8752-1340
Victoria RigualDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.ORCID https://orcid.org/0000-0001-7216-1506
Juan C DomínguezDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.ORCID https://orcid.org/0000-0002-7930-5979
M Virginia AlonsoDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.
Mercedes OlietDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.ORCID https://orcid.org/0000-0001-8792-3497
Francisco RodriguezDepartment of Chemical Engineering and Materials, Complutense University of Madrid 28040 Madrid Spain antonioo@ucm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wood fractionation is key for the integral valorization of its three main components. In this sense, recovering the hemicellulosic fraction after the ionosolv treatment of lignocellulosic materials is one of the main drawbacks of this process. Thus, the incorporation of a previous autohydrolyisis step to recover the hemicellulosic sugars before the ionosolv treatment is an interesting approach. The influence of both treatments, autohydrolysis and ionosolv, on the biomass fractions recovery yields was studied by a central composite design of experiments, varying the autohydrolysis temperature in a 175-195 °C range and ionosolv time between 1-5 h. Lignin recovery and cellulose purity were maximized at 184 °C and 3.5 h of autohydrolysis temperature and ionosolv time, respectively. In addition, lignin properties were incorporated to the statistical model, revealing lignin recondensation at severe conditions and a higher influence of the ionosolv treatment on lignin characteristics. These results remarked the importance of studying the effect of both treatments in the whole fractionation process and not each process separately and enhanced the understanding of the treatments combination in a complete fractionation biorefinery approach.

Identifiers

PMID37020891
PMCPMC10068429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.